Stearns Mark E, Hu Youji, Wang Min
Department of Pathology and Laboratory, Drexel University College of Medicine, 15th and Vine Sts, Philadelphia, PA 19102-1192, USA.
Oncogene. 2003 Jun 12;22(24):3781-91. doi: 10.1038/sj.onc.1206579.
Interleukin 10 (IL-10) stimulates rapid nuclear translocation and binding of a 22 kDa protein, termed interleukin 10 enhancer 1 (IL-10E1), to a novel enhancer element (i.e. HTE-1) of the tissue inhibitor of metalloproteinase-1 (TIMP-1) gene to upregulate TIMP-1 expression. IL-10E1 signaling involves tyrosine phosphorylation of the IL-10R JAK1 (Janus kinase) and TYK2 (tyrosine kinase) receptor kinases and tyrosine phosphorylation of two tyrosine moieties (Y57 and Y62) of a LIM domain of the IL-10E1 protein. In this paper, the studies showed that two tyrosine residues (Tyr(446) and Tyr(496)) located in the cytoplasmic domain of the IL-10R alpha chain were required for receptor function, and for phosphorylation and activation of IL-10E1. Immunoprecipitation studies revealed that 12 amino-acid peptides encompassing either of these two tyrosine residues in phosphorylated form coprecipitated IL-10E1 and blocked ligand-dependent IL-10E1 phosphorylation in a cell-free system. In contrast, peptides containing serine substitutions for Tyr(446) and Tyr(496), and tyrosine-phosphorylated peptides containing Tyr(230) or Tyr(252/259) did not prevent IL-10E1 activation or signaling. To confirm these observations in vivo, fusion protein constructs were made between a modified form of green fluorescent protein or GFP and the intact IL-10E1 protein (IL-10E1-MmGFP) and n-terminal peptides of the IL-10E1 protein (i.e. nt-nls-MmGFP and mutant sequences identified as nt-nls mC61-MmGFP and nt-nls mY57/mY62-MmGFP peptides). Confocal microscopy revealed that IL-10 triggered transport to the nucleus of IL-10E1-MmGFP, nt-nls-MmGFP, and nt-nls mC61-MmGFP by 10-30 min in HPCA-10a (human prostrate cancer cells; derived from Gleason sum 10 tumor tissue) cells. IL-10 failed to induce nuclear translocation of the mY57/mY62-MmGFP peptides with point mutations of the two tyrosine groups. Coinjection of nt-nls-MmGFP with the IL-10R Tyr(446) and Tyr(496) amino-acid residues completely blocked ligand signaling. Coinjection of peptides containing either serine substitutions for Tyr(446) and Tyr(496) or Tyr(230) and Tyr(252/259) failed to block nt-nls-MmGFP signaling. The data demonstrate that IL-10E1 is directly recruited to the ligand-activated IL-10R by binding to specific phosphotyrosine groups which control tyrosine phosphorylation of the LIM domain of the IL-10E1 protein (i.e. Y57/Y62 groups) and IL-10E1 activation.
白细胞介素10(IL-10)刺激一种22 kDa蛋白(称为白细胞介素10增强子1,IL-10E1)快速发生核转位并与金属蛋白酶组织抑制剂-1(TIMP-1)基因的一个新型增强子元件(即HTE-1)结合,从而上调TIMP-1的表达。IL-10E1信号传导涉及IL-10R JAK1(Janus激酶)和TYK2(酪氨酸激酶)受体激酶的酪氨酸磷酸化以及IL-10E1蛋白一个LIM结构域的两个酪氨酸残基(Y57和Y62)的酪氨酸磷酸化。在本文中,研究表明IL-10Rα链胞质结构域中的两个酪氨酸残基(Tyr(446)和Tyr(496))对于受体功能以及IL-10E1的磷酸化和激活是必需的。免疫沉淀研究显示,包含这两个酪氨酸残基中任何一个的磷酸化形式的12个氨基酸肽能共沉淀IL-10E1,并在无细胞系统中阻断配体依赖性的IL-10E1磷酸化。相比之下,用丝氨酸替代Tyr(446)和Tyr(496)的肽,以及包含Tyr(230)或Tyr(252/259)的酪氨酸磷酸化肽并不能阻止IL-10E1的激活或信号传导。为了在体内证实这些观察结果,构建了绿色荧光蛋白(GFP)的修饰形式与完整的IL-10E1蛋白(IL-10E1-MmGFP)以及IL-10E1蛋白的n端肽(即nt-nls-MmGFP以及鉴定为nt-nls mC61-MmGFP和nt-nls mY57/mY62-MmGFP肽的突变序列)之间的融合蛋白构建体。共聚焦显微镜显示,在HPCA-10a(人前列腺癌细胞;源自Gleason评分10的肿瘤组织)细胞中,IL-10在10 - 30分钟内触发IL-10E1-MmGFP、nt-nls-MmGFP和nt-nls mC61-MmGFP转运至细胞核。IL-10未能诱导两个酪氨酸基团发生点突变的mY57/mY62-MmGFP肽的核转位。将nt-nls-MmGFP与IL-10R Tyr(446)和Tyr(496)氨基酸残基共注射完全阻断了配体信号传导。将用丝氨酸替代Tyr(446)和Tyr(496)或Tyr(230)和Tyr(252/259)的肽共注射未能阻断nt-nls-MmGFP信号传导。数据表明IL-10E1通过与控制IL-10E1蛋白LIM结构域酪氨酸磷酸化(即Y57/Y62基团)和IL-10E1激活的特定磷酸酪氨酸基团结合而直接被招募至配体激活的IL-10R。